{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:49:49Z","timestamp":1790192989506,"version":"4.1.0"},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Lacryglobin has been identified in human tears. This protein has high sequence homology to the mammaglobins, proteins upregulated in breast cancer and in breast cancer metastasis. In order to investigate the utility of tear screening for cancer, tear samples were collected from patients with different types of cancer and compared to controls. Tear samples were taken from five controls and eight breast, six lung, five colon, one prostate and three ovary cancer patients. Tears were analysed using 2\u2010D gel electrophoresis (<jats:italic>n<\/jats:italic> = 25) and 1\u2010D electrophoresis (<jats:italic>n<\/jats:italic> = 3). Lacryglobin was present in the following percentage of patients: breast cancer (88%), lung (83%), colon (100%), ovary (33%), prostate (100%) and controls (60%). Two control patients with lacryglobin had a family history of breast and prostate cancer. Lacryglobin was detected in some but not all tear samples and further studies are warranted to investigate its potential as a marker for cancer.<\/jats:p>","DOI":"10.1046\/j.1442-9071.2001.00408.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:58:46Z","timestamp":1047380326000},"page":"161-163","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Lacryglobin in human tears, a potential marker for cancer"],"prefix":"10.1111","volume":"29","author":[{"given":"Victoria","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Vockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark DP","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"MolloyMet al.Electrophoresis1997;18: 2811\u201315."},{"key":"e_1_2_6_3_2","unstructured":"WatsonMet al.Cancer Res.1996;56: 860\u201365."},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","unstructured":"MinCJ.Cancer Res.1998;58: 4581\u20134.","DOI":"10.1103\/PhysRevA.58.4581"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"AiharaTet al.Breast Cancer Res. Treat.1999;58: 137\u201340.","DOI":"10.1023\/A:1006335817889"},{"key":"e_1_2_6_6_2","unstructured":"BeckerRet al.Genomics1998;54: 70\u201374."},{"key":"e_1_2_6_7_2","unstructured":"GrunewaldKet al.Lab. Invest.2000;80: 1071\u20137."},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","unstructured":"AiharaTet al.Cancer Lett.2000;150: 79\u201384.","DOI":"10.1016\/S0304-3835(99)00378-X"},{"key":"e_1_2_6_9_2","unstructured":"ZhaoCet al.Biochem. Biophys. Res. Commun. 1999;256: 147\u201355."},{"key":"e_1_2_6_10_2","unstructured":"WatsonMAet al.Oncogene1998;16: 817\u201324."},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","unstructured":"LehrerRet al.FEBS Lett.1998;432: 163\u20137.","DOI":"10.1016\/S0014-5793(98)00852-7"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","unstructured":"EvansVet al.Clin. Exp. Ophthalmol.2000;28: 208\u201311.","DOI":"10.1046\/j.1442-9071.2000.00285.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","unstructured":"YatesJR.J. Mass Spectrom.1998;33: 1\u201319.","DOI":"10.1002\/(SICI)1096-9888(199801)33:1<1::AID-JMS624>3.0.CO;2-9"},{"key":"e_1_2_6_14_2","unstructured":"CottrellJ.Pept. Res.1994;7: 115\u201324."}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-9071.2001.00408.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-9071.2001.00408.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T17:15:09Z","timestamp":1697562909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-9071.2001.00408.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1442-9071.2001.00408.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-9071.2001.00408.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}